Literature DB >> 15368077

Allogeneic stem cell transplantation for treatment of immunodeficiency.

Wilhelm Friedrich1, Susanna M Müller.   

Abstract

Primary immunodeficiencies constitute a group of highly complex congenital disorders commonly characterized by an extremely poor prognosis. Allogeneic hematopoietic stem cell transplantation has the potential to establish a permanently functioning immune system and represents a curative approach in many of these disorders. In this review several aspects of stem cell transplantation are presented, with an emphasis on the mechanism of immune reconstitution in severe combined immunodeficiency diseases. In this disorder transplant modalities vary, and also include transplantation without cytoreductive conditioning. Clinical results are summarized based on recent analysis performed in large patient cohorts, which have shown steady improvements and have led to a marked change in the prognosis of patients with primary immunodeficiencies.

Entities:  

Mesh:

Year:  2004        PMID: 15368077     DOI: 10.1007/s00281-004-0158-2

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  36 in total

Review 1.  In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers.

Authors:  A W Flake; E D Zanjani
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

Review 2.  The Wiskott-Aldrich syndrome.

Authors:  A J Thrasher; C Kinnon
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 3.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

4.  Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency.

Authors:  M S Pollack; D Kirkpatrick; N Kapoor; B Dupont; R J O'Reilly
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

5.  Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.

Authors:  D D Patel; M E Gooding; R E Parrott; K M Curtis; B F Haynes; R H Buckley
Journal:  N Engl J Med       Date:  2000-05-04       Impact factor: 91.245

6.  Neonatal bone marrow transplantation for severe combined immunodeficiency.

Authors:  L Kane; A R Gennery; B N Crooks; T J Flood; M Abinun; A J Cant
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

7.  Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients.

Authors:  S M Müller; M Ege; A Pottharst; A S Schulz; K Schwarz; W Friedrich
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

8.  Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency.

Authors:  D Moshous; I Callebaut; R de Chasseval; B Corneo; M Cavazzana-Calvo; F Le Deist; I Tezcan; O Sanal; Y Bertrand; N Philippe; A Fischer; J P de Villartay
Journal:  Cell       Date:  2001-04-20       Impact factor: 41.582

9.  The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.

Authors:  J M Puck; S M Deschênes; J C Porter; A S Dutra; C J Brown; H F Willard; P S Henthorn
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

10.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).

Authors:  P Macchi; A Villa; S Giliani; M G Sacco; A Frattini; F Porta; A G Ugazio; J A Johnston; F Candotti; J J O'Shea
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

View more
  2 in total

Review 1.  Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects.

Authors:  Myriam N Bouchlaka; Doug Redelman; William J Murphy
Journal:  Immunotherapy       Date:  2010-05       Impact factor: 4.196

2.  Hematopoietic stem cell transplantation for pediatric patients with primary immunodeficiency diseases at All Children's Hospital/University of South Florida.

Authors:  A Petrovic; M Dorsey; J Miotke; C Shepherd; N Day
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.